Molecular Biology Reports

, Volume 40, Issue 6, pp 3969–3976 | Cite as

Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy

  • Yubao Zou
  • Jizheng Wang
  • Xuan Liu
  • Yilu Wang
  • Yi Chen
  • Kai Sun
  • Shuo Gao
  • Channa Zhang
  • Zhimin Wang
  • Yin Zhang
  • Xinxing Feng
  • Ying Song
  • Yajie Wu
  • Hongju Zhang
  • Lei Jia
  • Hu Wang
  • Dong Wang
  • Chaowu Yan
  • Minjie Lu
  • Xianliang Zhou
  • Lei Song
  • Rutai Hui
Article

Abstract

Genotype-phenotype correlation of hypertrophic cardiomyopathy (HCM) has been challenging because of the genetic and clinical heterogeneity. To determine the mutation profile of Chinese patients with HCM and to correlate genotypes with phenotypes, we performed a systematic mutation screening of the eight most commonly mutated genes encoding sarcomere proteins in 200 unrelated Chinese adult patients using direct DNA sequencing. A total of 98 mutations were identified in 102 mutation carriers. The frequency of mutations in MYH7, MYBPC3, TNNT2 and TNNI3 was 26.0, 18.0, 4.0 and 3.5 % respectively. Among the 200 genotyped HCM patients, 83 harbored a single mutation, and 19 (9.5 %) harbored multiple mutations. The number of mutations was positively correlated with the maximum wall thickness. We found that neither particular gene nor specific mutation was correlated to clinical phenotype. In summary, the frequency of multiple mutations was greater in Chinese HCM patients than in the Caucasian population. Multiple mutations in sarcomere protein may be a risk factor for left ventricular wall thickness.

Keywords

Hypertrophic cardiomyopathy Multiple gene mutations Left ventricular hypertrophy 

Notes

Acknowledgments

This study was supported by the Ministry of Science and Technology of China (grant number 2007DFC30340 and 2009DFB30050) and by the National Natural Science Foundation of China (grant number 30971233). We thank the patients for participating in the study. We are grateful to Ferhaan Ahmad for critical reading and helpful ideas of the manuscript.

References

  1. 1.
    Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287:1308–1320PubMedCrossRefGoogle Scholar
  2. 2.
    Zou Y, Song L, Wang Z, Ma A, Liu T, Gu H et al (2004) Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am J Med 116:14–18PubMedCrossRefGoogle Scholar
  3. 3.
    Marian AJ (2010) Hypertrophic cardiomyopathy: from genetics to treatment. Eur J Clin Invest 40:360–369PubMedCrossRefGoogle Scholar
  4. 4.
    Konno T, Chang S, Seidman JG, Seidman CE (2010) Genetics of hypertrophic cardiomyopathy. Curr Opin Cardiol 25(3):205–209PubMedCrossRefGoogle Scholar
  5. 5.
    Williams JR (2008) The Declaration of Helsinki and public health. Bull World Health Organ 86:650–651PubMedCrossRefGoogle Scholar
  6. 6.
    McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M (1997) Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 77:130–132PubMedGoogle Scholar
  7. 7.
    Simpson DA, Clark GR, Alexander S, Silvestri G, Willoughby CE (2011) Molecular diagnosis for heterogeneous genetic diseases with targeted high-throughput DNA sequencing applied to retinitis pigmentosa. J Med Genet 48(3):145–151PubMedCrossRefGoogle Scholar
  8. 8.
    Jordan DM, Kiezun A, Baxter SM, Agarwala V, Green RC, Murray MF et al (2011) Development and validation of a computational method for assessment of missense variants in hypertrophic cardiomyopathy. Am J Hum Genet 88(2):183–192PubMedCrossRefGoogle Scholar
  9. 9.
    Van Driest SL, Ellsworth EG, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ (2003) Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 108:445–451PubMedCrossRefGoogle Scholar
  10. 10.
    Olivotto I, Girolami F, Ackerman MJ, Nistri S, Bos JM, Zachara E et al (2008) Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clin Proc 83:630–638PubMedGoogle Scholar
  11. 11.
    Millat G, Bouvagnet P, Chevalier P, Dauphin C, Jouk PS, Da Costa A et al (2010) Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. Eur J Med Genet 53:261–267PubMedCrossRefGoogle Scholar
  12. 12.
    Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ et al (2004) Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 44:1903–1910PubMedCrossRefGoogle Scholar
  13. 13.
    Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C et al (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107:2227–2232PubMedCrossRefGoogle Scholar
  14. 14.
    Richard P, Isnard R, Carrier L, Dubourg O, Donatien Y, Mathieu B et al (1999) Double heterozygosity for mutations in the b-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy. J Med Genet 36:542–545PubMedGoogle Scholar
  15. 15.
    Ingles J, Doolan A, Chiu C, Seidman J, Seidman C, Semsarian C (2005) Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet 42:e59PubMedCrossRefGoogle Scholar
  16. 16.
    Girolami F, Ho CY, Semsarian C, Baldi M, Will ML, Baldini K et al (2010) Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. J Am Coll Cardiol 55:1444–1453PubMedCrossRefGoogle Scholar
  17. 17.
    Otsuka H, Arimura T, Abe T, Kawai H, Aizawa Y, Kubo T et al (2012) Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy. Circ J 76(2):453–461PubMedCrossRefGoogle Scholar
  18. 18.
    Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, Kucherlapati R et al (2008) Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med 358:1899–1908PubMedCrossRefGoogle Scholar
  19. 19.
    Landstrom AP, Ackerman MJ (2010) Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy. Circulation 122:2441–2449PubMedCrossRefGoogle Scholar
  20. 20.
    Tsoutsman T, Kelly M, Ng DC, Tan JE, Tu E, Lam L et al (2008) Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Circulation 117:1820–1831PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Yubao Zou
    • 1
  • Jizheng Wang
    • 2
  • Xuan Liu
    • 2
  • Yilu Wang
    • 2
  • Yi Chen
    • 3
  • Kai Sun
    • 2
  • Shuo Gao
    • 2
  • Channa Zhang
    • 2
  • Zhimin Wang
    • 4
  • Yin Zhang
    • 1
  • Xinxing Feng
    • 1
  • Ying Song
    • 1
  • Yajie Wu
    • 1
  • Hongju Zhang
    • 4
  • Lei Jia
    • 2
  • Hu Wang
    • 2
  • Dong Wang
    • 1
  • Chaowu Yan
    • 5
  • Minjie Lu
    • 5
  • Xianliang Zhou
    • 6
  • Lei Song
    • 1
    • 6
  • Rutai Hui
    • 1
    • 2
    • 6
  1. 1.Department of CardiologyState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingPeople’s Republic of China
  2. 2.Sino-German Laboratory for Molecular MedicineState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingPeople’s Republic of China
  3. 3.Surgical ICUState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingPeople’s Republic of China
  4. 4.Department of EchocardiographyState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingPeople’s Republic of China
  5. 5.Department of RadiologyState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingPeople’s Republic of China
  6. 6.Hypertension CenterState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingPeople’s Republic of China

Personalised recommendations